Connect your AI

Ventas VTR Outpatient medical and research portfolio (OM&R) — Goodwill

Similar metrics at other companies

AHROutpatient Medical — Goodwill

$47.81M0.0%

WELLOutpatient Medical — Goodwill

$68.32M0.0%

DOCOutpatient medical — Goodwill

$64.68M0.0%

AVNSPM&R — Goodwill

$52.7M-58.9%

UNHOptum Rx — Goodwill

$21.81B+0.2%

GNLOffice — Goodwill

$11.8M-16.9%

Other financials

Income statement

Revenue$1.7B+22.0%

Net income$59.0M+22.1%

EPS (diluted)$0.11+10.0%

Balance sheet

Cash & equivalents$183.6M+0.7%

Total debt$12.7B-1.5%

Total equity$13.1B+14.4%

Total assets$27.7B+6.4%

Cash flow

Operating cash flow$394.6M+22.9%

Valuation

Market cap$42.51B+50.8%

Enterprise value$55.05B+34.5%

P/E156.2×-32.7×

P/S6.9×+1.4×

Profitability

Net margin4.4%+1.5pp

FCF margin33.1%—

Returns & leverage

Return on equity2.2%+0.8pp

Debt / equity1×-0.2×

Where this comes from

Reported directly by Ventas in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Ventas’s 10-K, filed February 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ventas's outpatient medical and research portfolio (om&r) — goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Ventas's outpatient medical and research portfolio (OM&R) — goodwill?: Ventas (VTR) reported outpatient medical and research portfolio (OM&R) — goodwill of $466.97M in Q4 2025.
What does outpatient medical and research portfolio (OM&R) — goodwill mean?: The intangible asset value representing the premium paid for acquisitions within the outpatient medical and research segment over the fair value of the identifiable net assets. It reflects the value of synergies, market presence, and tenant relationships acquired.